CARMIEL, Israel--(BUSINESS WIRE)--Protalix BioTherapeutics, Inc. (NYSE Alternext US:PLX), today announced that Dr. David Aviezer, the Company’s President and Chief Executive Officer, will be participating in the Credit Suisse Global Biotechnology, Biopharma and Generics One-on-One Conference, March 4-5, 2009 at the offices of Credit Suisse, Canary Wharf, London. The concept of the conference is to provide investors with the opportunity to have detailed and focused one-on-one and small group meetings with senior management from a range of over 50 global healthcare companies.
